{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:27:32Z","timestamp":1791941252506,"version":"4.3.4"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:sec id=\"ab-ioi250066-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Deceased donor kidney transplant is the preferred treatment for people with kidney failure, but survival benefits are likely to vary by donor quality and recipient characteristics. Prior studies may have overestimated these benefits due to immortal time bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi250066-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate the survival benefits of deceased donor kidney transplant compared with remaining on the waitlist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi250066-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This population-based cohort study used a clone-censor-weight approach to emulate a randomized clinical trial with data from the Australia and New Zealand Dialysis and Transplant Registry (January 1, 2010, to December 31, 2021). Data analysis was conducted from January 2025 to April 2025. Patients waitlisted in Australia were categorized into 3 groups: (1) transplant from kidneys with low Kidney Donor Risk Index (KDRI) scores less than the 90th percentile, (2) transplant from kidneys with a high KDRI score equal to or greater than the 90th percentile, and (3) those waitlisted while receiving dialysis only (never received a transplant).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi250066-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was all-cause mortality. The 10-year risk differences, risk ratios, and restricted mean survival time differences were estimated from inverse probability\u2013weighted pooled logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi250066-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 8011 patients who were waitlisted (median [IQR] age, 53.0 [42.0-62.0] years; 2902 [36.2%] were female), the estimated 10-year all-cause mortality was 22.4% (95% CI, 20.8%-24.2%) for the low KDRI group, 30.6% (95% CI, 24.8%-37.2%) for the high KDRI group, and 39.1% (95% CI, 33.2%-45.1%) for waitlisted patients. Compared with waitlisting, mean survival gains were 6.6 months (95% CI, 4.4-8.7) for kidneys with a low KDRI score and 3.6 months (95% CI, 0.3-6.4) for kidneys with a high KDRI score. Benefits were greatest for older recipients (\u226560 years) who received low KDRI\u2013scoring kidneys, showing a 35.8% reduction in mortality risk (95% CI, \u221250.2% to \u221221.0%). No survival benefit was observed in younger recipients (&amp;amp;lt;60 years) who received high KDRI\u2013scoring kidneys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ioi250066-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The results of this cohort study suggest that deceased donor kidney transplant is associated with improved survival compared with dialysis, but survival benefits vary by donor quality and recipient characteristics. High KDRI\u2013scoring kidneys are associated with modest survival gains, with limited survival benefits observed among younger recipients. These findings highlight the need for tailored counseling and shared decision-making to align treatment choices with individual risks and expected outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamainternmed.2025.5624","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:31:08Z","timestamp":1761579068000},"page":"1471","source":"Crossref","is-referenced-by-count":11,"title":["Survival Benefits of Deceased Donor Kidney Transplant vs Waitlisting"],"prefix":"10.1001","volume":"185","author":[{"given":"Lin","family":"Zhu","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Teixeira-Pinto","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Centre for Kidney Research, Kids Research Institute, The Children\u2019s Hospital at Westmead, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gately","sequence":"additional","affiliation":[{"name":"Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Boroumand","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Shuvo","family":"Bakar","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharshana","family":"Sabanayagam","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Centre for Kidney Research, Kids Research Institute, The Children\u2019s Hospital at Westmead, Sydney, New South Wales, Australia"},{"name":"Department of Renal and Transplantation Medicine, Westmead Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona F.","family":"Stanaway","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai H.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia"},{"name":"School of Health Sciences, Edith Cowan University, Perth, Western Australia, Australia"},{"name":"Medical School, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Centre for Kidney Research, Kids Research Institute, The Children\u2019s Hospital at Westmead, Sydney, New South Wales, Australia"},{"name":"Department of Renal and Transplantation Medicine, Westmead Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"ioi250066r1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029591","article-title":"Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"issue":"23","key":"ioi250066r2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"21","key":"ioi250066r3","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1001\/jama.294.21.2726","article-title":"Deceased-donor characteristics and the survival benefit of kidney transplantation.","volume":"294","author":"Merion","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"ioi250066r4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/TP.0000000000002476","article-title":"Establishing a core outcome measure for life participation: a standardized outcomes in nephrology-kidney transplantation consensus workshop report.","volume":"103","author":"Ju","year":"2019","journal-title":"Transplantation"},{"issue":"2","key":"ioi250066r5","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000974","article-title":"Cost-effectiveness of deceased-donor renal transplant versus dialysis to treat end-stage renal disease: a systematic review.","volume":"6","author":"Fu","year":"2020","journal-title":"Transplant Direct"},{"issue":"10","key":"ioi250066r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.34971","article-title":"Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure.","volume":"5","author":"Strohmaier","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"ioi250066r7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40471-019-0180-5","article-title":"Immortal time bias in epidemiology.","volume":"6","author":"Platt","year":"2019","journal-title":"Curr Epidemiol Rep"},{"issue":"3","key":"ioi250066r9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/ckj\/sfac243","article-title":"Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time.","volume":"16","author":"Prunster","year":"2022","journal-title":"Clin Kidney J"},{"issue":"3","key":"ioi250066r10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/ajt.15656","article-title":"Insights into the labeling effect of Kidney Donor Performance Index reporting: the Australian experience.","volume":"20","author":"Sypek","year":"2020","journal-title":"Am J Transplant"},{"issue":"3","key":"ioi250066r11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s40471-024-00346-2","article-title":"The clone-censor-weight method in pharmacoepidemiologic research: foundations and methodological implementation.","volume":"11","author":"Gaber","year":"2024","journal-title":"Curr Epidemiol Rep"},{"issue":"24","key":"ioi250066r12","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data.","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"ioi250066r13","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"9","key":"ioi250066r14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074626","article-title":"Development of the Transparent Reporting of Observational Studies Emulating a Target trial (TARGET) guideline.","volume":"13","author":"Hansford","year":"2023","journal-title":"BMJ Open"},{"issue":"21","key":"ioi250066r15","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1056\/NEJMp2407586","article-title":"\u201cTarget trial emulation\u201d for observational studies\u2014potential and pitfalls.","volume":"391","author":"Hubbard","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"ioi250066r16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2215\/CJN.03320708","article-title":"The declaration of Istanbul on organ trafficking and transplant tourism.","volume":"3","author":"International Summit on Transplant Tourism and Organ Trafficking","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"ioi250066r17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","article-title":"A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.","volume":"88","author":"Rao","year":"2009","journal-title":"Transplantation"},{"issue":"13","key":"ioi250066r19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jama.280.13.1148","article-title":"Barriers to cadaveric renal transplantation among blacks, women, and the poor.","volume":"280","author":"Alexander","year":"1998","journal-title":"JAMA"},{"key":"ioi250066r20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068769","article-title":"Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis.","volume":"376","author":"Chaudhry","year":"2022","journal-title":"BMJ"},{"issue":"3","key":"ioi250066r21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/ckj\/sfx117","article-title":"A comparative analysis of survival of patients on dialysis and after kidney transplantation.","volume":"11","author":"Kaballo","year":"2018","journal-title":"Clin Kidney J"},{"issue":"2","key":"ioi250066r22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/EDE.0000000000001308","article-title":"Clinical trial emulation by matching time-dependent propensity scores: the example of estimating impact of kidney transplantation.","volume":"32","author":"Lenain","year":"2021","journal-title":"Epidemiology"},{"issue":"1","key":"ioi250066r23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2215\/CJN.07620621","article-title":"Waiting time for second kidney transplantation and mortality.","volume":"17","author":"Kainz","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"ioi250066r24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S2213-8587(24)00241-9","article-title":"Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France.","volume":"12","author":"Maanaoui","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ioi250066r8","unstructured":"Lee? D, Davies? C, Au? E, . 47th Report, chapter 6: Australian transplant waiting list. Accessed August 30, 2025. https:\/\/www.anzdata.org.au\/wp-content\/uploads\/2024\/12\/06_waiting_list_2023_ar_2024_chapter_F_20241224.pdf"},{"key":"ioi250066r18","unstructured":"Thoracic Society of Australia and New Zealand. A guide to the Australian Kidney Donor Profile Index (KDPI). https:\/\/tsanz.com.au\/storage\/documents\/AustralianKDPIINFOv10.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2840564\/jamainternal_zhu_2025_oi_250066_1769197431.38592.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:00:34Z","timestamp":1769443234000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2840564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2025.5624","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}